Skip to main content
. 2022 Jan 17;27(1):37–43. doi: 10.6065/apem.2142110.055

Table 2.

Growth response after growth hormone treatment

Parameter All patients (n = 692) ISS (n = 98) Partial GHD (n = 443) Complete GHD (n = 151) P-value Post hoc *
Ht velocity (cm/yr)
1st year 9.09±1.65 8.72±1.64 9.04±1.55 9.52±1.93 0.181
2nd year 7.48±1.41 6.97±0.75 7.41±1.44 7.99±1.43 0.050
During 2 years 8.28±1.15 8.27±1.09 8.19±1.08 8.55±1.36 0.451
ΔHt-SDS
1st year 0.85±0.39 0.78±0.40 0.83±0.34 0.96±0.51 0.218
2nd year 0.41±0.27 0.29±0.14 0.39±0.26 0.53±0.34 0.032 a>b, c
During 2 years 1.26±0.50 1.24±0.47 1.20±0.41 1.42±0.70 0.235
ΔBMI-SDS
1st year -0.23±0.58 -0.25±0.62 -0.23±0.57 -0.19±0.58 0.667
2nd year 0.03±0.42 -0.04±0.49 0.03±0.36 0.03± 0.56 0.765
During 2 years -0.18±0.59 -0.31±0.52 -0.18±0.61 -0.13±0.54 0.640
Δ (BA−CA)
1st year -0.24±1.02 -0.31±0.77 -0.22±1.08 -0.23±0.96 0.939
2nd year 0.36±0.98 0.07±0.73 0.34±1.02 0.54±0.94 0.363
During 2 years 0.16±1.28 -0.26±1.19 0.17±1.23 0.31±1.44 0.275

Values are presented as mean±standard deviation.

ISS, idiopathic short stature; GHD, growth hormone deficiency; Ht, height; SDS, standard deviation score; BMI, body mass index; BA, bone age; CA, chronological age.

*

Multiple comparsion: Bonferroni (a=ISS; b=partial GHD; c=complete GHD).